GeneDx (WGS) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $70.22, +2.35% vs the prior close of $68.61.
- Volume 796.60K shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
WGS rises 2.3% to $70.22, 3 up days in a row. Closed at $70.22, +2.35% vs the prior close of $68.61. Day range $66.35–$72.70, opened at $68.50.
WGS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — WGS rises 2.3% to $70.22, 3 up days in a row
- Closed at $70.22, +2.35% vs the prior close of $68.61. Day range $66.35–$72.70, opened at $68.50.
- Volume was 796.60K shares, 1.2x its 50-day average of 672.22K.
- Price is -14.2% vs its 50-day average ($81.89) and -6.8% vs its 200-day average ($75.33).
- 52-week range $32.21–$170.87; today's close sits at 27% of that range, 58.9% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 — WGS jumps 5.6% to $68.61
- Closed at $68.61, +5.62% vs the prior close of $64.96. Day range $63.50–$69.32, opened at $64.13.
- Volume was 962.10K shares, 1.4x its 50-day average of 706.17K.
- Price is -16.2% vs its 50-day average ($81.88) and -9.3% vs its 200-day average ($75.63).
- 52-week range $32.21–$170.87; today's close sits at 26% of that range, 59.8% below the 52-week high.
Oct 13, 2026 — WGS rises 1.8% to $64.96
- Closed at $64.96, +1.79% vs the prior close of $63.82. Day range $62.01–$66.41, opened at $62.70.
- Volume was 526.60K shares, 0.7x its 50-day average of 730.41K.
- Price is -20.7% vs its 50-day average ($81.93) and -14.5% vs its 200-day average ($75.95).
- 52-week range $32.21–$170.87; today's close sits at 24% of that range, 62.0% below the 52-week high.
Oct 12, 2026 — WGS slides 5.2% to $63.82, a 1-month low, 5 down days in a row
- Closed at $63.82, -5.21% vs the prior close of $67.33. Day range $63.50–$67.33, opened at $67.33.
- Volume was 491.10K shares, 0.7x its 50-day average of 738.31K.
- Price is -22.2% vs its 50-day average ($81.98) and -16.4% vs its 200-day average ($76.31).
- 52-week range $32.21–$170.87; today's close sits at 23% of that range, 62.6% below the 52-week high.
- That makes 5 straight losses.
Oct 9, 2026 — WGS dips 0.6% to $67.33, a 1-month low, 4 down days in a row
- Closed at $67.33, -0.59% vs the prior close of $67.73. Day range $67.22–$69.73, opened at $68.45.
- Volume was 404.70K shares, 0.5x its 50-day average of 747.04K — lighter than usual.
- Price is -17.9% vs its 50-day average ($82.01) and -12.2% vs its 200-day average ($76.67).
- 52-week range $32.21–$170.87; today's close sits at 25% of that range, 60.6% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — WGS dips 1.2% to $67.73, a 1-month low, 3 down days in a row
- Closed at $67.73, -1.17% vs the prior close of $68.53. Day range $64.50–$67.94, opened at $67.41.
- Volume was 734.60K shares, 1.0x its 50-day average of 752.87K.
- Price is -17.4% vs its 50-day average ($82.04) and -12.1% vs its 200-day average ($77.03).
- 52-week range $32.21–$170.87; today's close sits at 26% of that range, 60.4% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — WGS slides 4.2% to $68.53, a 1-month low
- Closed at $68.53, -4.18% vs the prior close of $71.52. Day range $68.39–$71.43, opened at $70.31.
- Volume was 659.30K shares, 0.9x its 50-day average of 753.97K.
- Price is -16.4% vs its 50-day average ($81.96) and -11.5% vs its 200-day average ($77.39).
- 52-week range $32.21–$170.87; today's close sits at 26% of that range, 59.9% below the 52-week high.
Oct 6, 2026 — WGS slides 6.2% to $71.52
- Closed at $71.52, -6.23% vs the prior close of $76.27. Day range $70.24–$79.68, opened at $76.53.
- Volume was 816.60K shares, 1.1x its 50-day average of 749.87K.
- Price is -12.6% vs its 50-day average ($81.83) and -8.0% vs its 200-day average ($77.73).
- 52-week range $32.21–$170.87; today's close sits at 28% of that range, 58.1% below the 52-week high.
Oct 5, 2026 — WGS jumps 4.4% to $76.27
- Closed at $76.27, +4.35% vs the prior close of $73.09. Day range $72.04–$77.20, opened at $73.35.
- Volume was 855.20K shares, 1.2x its 50-day average of 741.36K.
- Price is -6.5% vs its 50-day average ($81.61) and -2.3% vs its 200-day average ($78.06).
- 52-week range $32.21–$170.87; today's close sits at 32% of that range, 55.4% below the 52-week high.
Oct 2, 2026 — WGS jumps 3.0% to $73.09
- Closed at $73.09, +3.00% vs the prior close of $70.96. Day range $70.48–$74.86, opened at $71.13.
- Volume was 606.70K shares, 0.8x its 50-day average of 736.67K.
- Price is -10.1% vs its 50-day average ($81.26) and -6.8% vs its 200-day average ($78.38).
- 52-week range $32.21–$170.87; today's close sits at 29% of that range, 57.2% below the 52-week high.
WGS latest news & SEC filings
Every SEC filing by or about WGS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Stueland Katherine converted options/RSUs into 18,750 shares on Sep 16, 2026; now holds 125,977
- Stueland Katherine sold 1,648 shares at $94.26 (≈$155.34K) on Sep 16, 2026; now holds 124,329
- Stueland Katherine sold 148 shares at $95.41 (≈$14.12K) on Sep 16, 2026; now holds 124,181
- Stueland Katherine sold 1,525 shares at $96.90 (≈$147.77K) on Sep 16, 2026; now holds 122,656
- Stueland Katherine sold 4,141 shares at $98.27 (≈$406.94K) on Sep 16, 2026; now holds 118,515
- Stueland Katherine sold 3,039 shares at $99.00 (≈$300.85K) on Sep 16, 2026; now holds 115,476
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Feeley Kevin converted options/RSUs into 7,197 shares on Sep 16, 2026; now holds 48,673
- Feeley Kevin sold 586 shares at $94.26 (≈$55.24K) on Sep 16, 2026; now holds 48,087
- Feeley Kevin sold 52 shares at $95.41 (≈$4.96K) on Sep 16, 2026; now holds 48,035
- Feeley Kevin sold 541 shares at $96.90 (≈$52.42K) on Sep 16, 2026; now holds 47,494
- Feeley Kevin sold 1,470 shares at $98.27 (≈$144.46K) on Sep 16, 2026; now holds 46,024
- Feeley Kevin sold 1,079 shares at $99.00 (≈$106.82K) on Sep 16, 2026; now holds 44,945
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 18, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Fuchs Thomas converted options/RSUs into 1,146 shares on Sep 17, 2026; now holds 1,146
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Stueland Katherine sold 3,692 shares at $84.22 (≈$310.94K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Feeley Kevin sold 1,285 shares at $84.22 (≈$108.22K) on Sep 9, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Feeley Kevin sold 372 shares at $83.84 (≈$31.19K) on Sep 1, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 11, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 3, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $114.44M (prior year $102.69M) (+11.4% vs Jun 30, 2025)
- Net income: -$17.74M (prior year $10.81M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.60 (prior year $0.36) (loss widened vs Jun 30, 2025)
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 21, 2026 · Form 25-NSE — Notice that a security is being removed from exchange listing
Notice that a security is being removed from exchange listing
Jun 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade WGS
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: May 4, 2026, Feb 23, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.99% (largest 11.8%). That is a volatile stock.
- Liquidity: about 834.65K shares (≈$58.61M) trade per day on average.
- 52-week position: $70.22 vs a range of $32.21–$170.87 (27% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 21 sales; latest: Katherine Stueland sold 4,141 shares on Sep 16, 2026.
- Latest filings: 10-Q Aug 3, 2026; 8-K Aug 3, 2026; 8-K Jun 23, 2026.
- Share count: 29.82M shares outstanding (Jul 27, 2026), +3.8% vs a year earlier.
- Listing: Nasdaq · industry: Services-Health Services.
WGS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 68.50 | 72.70 | 66.35 | 70.22 | 796.60K |
| Oct 14, 2026 | 64.13 | 69.32 | 63.50 | 68.61 | 962.10K |
| Oct 13, 2026 | 62.70 | 66.41 | 62.01 | 64.96 | 526.60K |
| Oct 12, 2026 | 67.33 | 67.33 | 63.50 | 63.82 | 491.10K |
| Oct 9, 2026 | 68.45 | 69.73 | 67.22 | 67.33 | 404.70K |
| Oct 8, 2026 | 67.41 | 67.94 | 64.50 | 67.73 | 734.60K |
| Oct 7, 2026 | 70.31 | 71.43 | 68.39 | 68.53 | 659.30K |
| Oct 6, 2026 | 76.53 | 79.68 | 70.24 | 71.52 | 816.60K |
| Oct 5, 2026 | 73.35 | 77.20 | 72.04 | 76.27 | 855.20K |
| Oct 2, 2026 | 71.13 | 74.86 | 70.48 | 73.09 | 606.70K |
| Oct 1, 2026 | 72.77 | 75.49 | 70.69 | 70.96 | 858.00K |
| Sep 30, 2026 | 75.74 | 75.81 | 72.11 | 72.30 | 905.00K |
| Sep 29, 2026 | 85.59 | 87.86 | 74.16 | 75.79 | 1.33M |
| Sep 28, 2026 | 87.33 | 89.32 | 84.90 | 85.93 | 437.00K |
| Sep 25, 2026 | 89.00 | 90.99 | 86.14 | 88.40 | 510.30K |
| Sep 24, 2026 | 84.46 | 93.51 | 83.10 | 88.48 | 1.55M |
| Sep 23, 2026 | 90.50 | 92.81 | 84.35 | 85.20 | 1.05M |
| Sep 22, 2026 | 95.19 | 95.19 | 87.33 | 90.80 | 1.69M |
| Sep 21, 2026 | 101.30 | 102.21 | 97.14 | 97.83 | 732.20K |
| Sep 18, 2026 | 104.59 | 105.00 | 99.70 | 101.10 | 786.10K |
About GeneDx
GeneDx (WGS) is listed on the Nasdaq and classified by the SEC under “Services-Health Services”. Its business address is in STAMFORD, CT. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1818331.
WGS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Capital, Llc Casdin | Director | Jun 8, 2026 |
| Eli Casdin | Director | Jun 23, 2026 |
| Partners Gp, Llc Casdin | Director | Jun 8, 2026 |
| Partners Master Fund, L.P. Casdin | Director | Jun 8, 2026 |
| Management Lp Corvex | Director | May 15, 2026 |
| Thomas Fuchs | Director | Sep 18, 2026 |
| Emily M. Leproust | Director | Jun 23, 2026 |
| Keith A. Meister | Director | Jun 23, 2026 |
| Richard C Jr Pfenniger | Director | Jun 23, 2026 |
| Joshua Ruch | Director | Jun 23, 2026 |
| Jason Ryan | Director | Jun 23, 2026 |
| Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sep 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Bryan Dechairo | Chief Operating Officer | Mar 5, 2026 |
| Kevin Feeley | CHIEF FINANCIAL OFFICER | Sep 18, 2026 |
| Mark A Gardner | President | Jul 1, 2026 |
| Katherine Stueland | CHIEF EXECUTIVE OFFICER | Sep 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 16, 2026 | Katherine Stueland | Sale | 4,141 | $98.27 |
| Sep 16, 2026 | Katherine Stueland | Sale | 1,525 | $96.90 |
| Sep 16, 2026 | Katherine Stueland | Sale | 148 | $95.41 |
| Sep 16, 2026 | Katherine Stueland | Sale | 1,648 | $94.26 |
| Sep 16, 2026 | Katherine Stueland | Sale | 3,039 | $99.00 |
| Sep 16, 2026 | Kevin Feeley | Sale | 586 | $94.26 |
| Sep 16, 2026 | Kevin Feeley | Sale | 1,079 | $99.00 |
| Sep 16, 2026 | Kevin Feeley | Sale | 541 | $96.90 |
| Sep 16, 2026 | Kevin Feeley | Sale | 1,470 | $98.27 |
| Sep 16, 2026 | Kevin Feeley | Sale | 52 | $95.41 |
| Sep 9, 2026 | Kevin Feeley | Sale | 1,285 | $84.22 |
| Sep 9, 2026 | Katherine Stueland | Sale | 3,692 | $84.22 |
| Sep 1, 2026 | Kevin Feeley | Sale | 372 | $83.84 |
| Jun 16, 2026 | Kevin Feeley | Sale | 2,106 | $60.83 |
| Jun 16, 2026 | Kevin Feeley | Sale | 863 | $61.50 |
WGS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $427.54M | $-21.02M | -0.73 | $33.28M |
| Dec 31, 2024 | $305.45M | $-52.29M | -1.94 | $-28.50M |
| Dec 31, 2023 | $202.57M | $-175.77M | -7.23 | $-180.15M |
| Dec 31, 2022 | $234.69M | $-548.98M | -53.63 | $-319.15M |
| Dec 31, 2021 | $212.19M | $-245.39M | -2.27 | $-190.43M |
Latest balance sheet: total assets $481.49M, total liabilities $237.26M, cash $60.32M (as of Jun 30, 2026).
WGS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $67.86 |
| May 4, 2026 | 8-K Item 2.02 (results) | $67.93 |
| Feb 23, 2026 | 8-K Item 2.02 (results) | $87.08 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $119.24 |
| Oct 28, 2025 | 8-K Item 2.02 (results) | $137.47 |
| Jul 29, 2025 | 8-K Item 2.02 (results) | $91.78 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $66.85 |
| Feb 18, 2025 | 8-K Item 2.02 (results) | $112.76 |
| Jan 13, 2025 | 8-K Item 2.02 (results) | $85.01 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $84.02 |
| Jul 30, 2024 | 8-K Item 2.02 (results) | — |
| Apr 29, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Health Services
Privia Health (PRVA)LifeStance Health (LFST)Omada Health (OMDA)U S Physical Therapy (USPH)Pennant (PNTG)Strata Critical Medical (SRTA)InnovAge (INNV)EUDA Health (EUDA)DocGo (DCGO)P3 Health Partners (PIII)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on WGS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.